OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

ontents ontents
Reference and administrative information 1 —2
Statement
from the CEO
3 —4
Statement
from the Chair
ofTrustees
Governance 6 —7
Background
and Strategy
8 —10
Strategic report —Objectives &activities
Mountbatten
pyramid
12 —13
Key Achievements
and Performance
14
Services across Mountbatten isle of Wight and Mountbatten Hampshire 15 —24
Quality 25 —35
Education
and Training
36 —37
Mandatory
training
38
Research 39
Income generation 40 —41
Communications 42 —44
Estates and Facilities 45 —47
Catenng 48
People Services 49 —54
Information
Technology
55 —57
Trustees'
duty to promote
the success of the Charity —Section 172statement 58 —60
Sustainabihty
and carbon
reporting 61
Finanaal
review
62
Public benefit statement 63
Statement
oftrustees'
responsibilities
64
Independent
auditor's
report
65 —67
Consolidated
statement
of financial
activities 68
(incorporating
an income
and expenditure account)
Balance sheet 69
Consolidated
statement
ofcash flows
70
Notes to the financial
statements
71 —97

Bankers: NatWest
NatWest
House
Riverway
Newport
Isle of Wight
PO30 SUX
Investment Managers: Brewin Dolphin (Retired March 2023)
Vantage Point
Woodwater Park
Pynes
Hill
Exeter
EX2 SFD
Investment Managers: CCLA Fund Managers Ltd
)appointed April 2023)
BSQueen Victona Street
London
EC4V 4ET
Investment Managers: Ruffer
LLP
(appointed Apnl 2023)
80Victona Street
London
SW1E SIL
Solicitors: Bates Wells LLP
10Queen Street Place
London
EC4R 1BE
Solicitors: Glanwlles LLP
St Cross Business Park
Newport
Isle of Wight
PO30 SBF
Auditor: Atets Audit Services Limited
Ashcombe Court
Woolsack Way
Godalming
Surrey
GU7 1LQ

2. We will meet the needs ofeveryone
who requires our care and support,
We will meet the needs ofeveryone
who requires our care and support,
ensuring
that no-one
is
ensuring
that no-one
is
ensuring
that no-one
is
ignored: ignored:
~ Further
development
of a Children
and Young Adults
Service in partnership
with Kissy Puppy (Isle of Wight) and
Naomi House and Jack's Place (Hampshire)
~ A continuation
and further
development
of dementia
services and services
for older, frail people
~ Advance Care Planning
—continuing
to identify people with long term conditions
including
older people with
frailty
~ Health and Social Care Education
~ Rapid Palliative
Care Discharge Faohtator at Unwersity
Hospital Southampton
to match the successful
model on
the Isle of Wight
~ Mountbatten
Coordmation
Centres —24/7 telephone
and visiting service across all
our communities
~ End of Life Domiciliary
Care provision
(Continuing
Health Care packages)
~ New chanty shop model
Has been designed to integrate
Retail, I-lospitality
and Clinical Services
3. We will make sure that everything
Mountbatten
offers is sustainable
for the benefit offuture generations:
~ A robust reserves
policy and Risk Register
~ A Estates task and finish group ensures that our estate is 'fit for purpose'
for future
generations.
Two
Capital
Appeals are now planned
for the commg year, one for each site
~ A bespoke 'sustainability'
strategic implementation
plan focusing on fundraising
and financial resilience
~ A detailed
'COVID-19' Action and Recovery
Plan which has now been fully integrated
into our strategic
plans
~ A new workforce
development
plan
is in process
~ Development
of our ongoing education
programmes
both for our partners
and our local communities
~ A new shops strategy
and a growth
plan for our Hampshire
shops headed
up
by the new Head of Retail Business
Development
and supported
by the Retail/shops
Advisory
Group
In order to further
support
our strategic
aims
we continue
to work
m partnership
for the benefit of our local
communities
with examples
as follows:
Isle of Wight
NHS Trust Community
Paediatric Team
Kissy Puppy Chanty
(The Sophie Rolf Trust) —with a unique
Advisory
Group
made up of key stakeholders
Isle ofWight
Local Authority

Priority 1: Safety Priority 1: Safety
Target How we measure success
1.1The implementation of All necessary drug formulanes are built
in SystmOne,
the
electronic prescnbing on the electronic patient record
Inpatient Unit at Mountbatten Isle All appropnate
employees
are
trained
in the use ofthe
ofWight Hospice Electronic Prescribing
function
in SystmOne
—do we
need
to explain what this means&
Other health professionals,
including
GP's and community
nurses are notified ofthe move to electromc prescribing in
SystmOne
Electronic Prescnbing
module
in SystmOne goes live.
12 Development of robust Pharmacist
is in post, has completed
an mduction,
and
has
Pharmacy provision at clear objectives set.
Mountbatten
Hampshire
Hospice Retain and develop
links with
the Royal South Hants
with the introduction of a Band Ba Pharmacy
service, building
links to enable rotational
staff
Speaahst Pharmacist role. exposure to the spemalism
of
palliative care Pharmacy and
provide cover in Band Ba Pharmacist's
absence.
Develop and agree robust medicines
management
audit
programme
working
in coniunction
with the Medicines
Safety and Optimisation
team.

Tar et How we measure success
2.1The implementation of Rehabilitation-led beds are available
and robust
rehabilitation-led beds on the procedures
are in
place to inform and support employees
Inpatient Unit at Mountbatten Isle in the provision of patient care
ofWight Hospice Awareness
training
is provided
so employees
understand
why rehabilitation-led
beds are appropriate
at a particular
stage of patient care
Training on the processes and procedures
is
provided to
medics and nurses
Data dashboard
in
place to monitor progress that is
reported
monthly
at the Quality
and Governance
Committee
Evaluate and share the outcomes of setting up
rehabilitation-led beds with other hospices

2.2 The implementation 2.2 The implementation of Nurse- Mountbatten
non-medical
prescribing
education
Led beds on the Inpatient Unit at programme
is approved
by Health Education
England
Mountbatten Hampshire Hospice There is a clinical supervision
structure
in place for
Advanced
Nurse Prescribers
facilitated
by the Medical
Team
Nurse-led
beds expanded
from respite
patients to include
patients
admitted
for iron-infusions
and step down beds
An evaluation
ofthe nurse-led
bed prolect will be
completed
and results
included
m the
Quahty
Report and
presented
at Quality and Governance
Committee

3:People's experience 3:People's experience 3:People's experience 3:People's experience
Priority 3: People's Experience
Target How we measure success
3.1Purchase additional land on the Land required to extend the car park has been
Mountbatten Isle of Wight Hospice site to purchased
allow for the reconfiguration of car parking The Gables and Oak House buildings
have been
which
will create increased
capacity demolished
by an approved
contractor
Design and layout for the car park has been
approved
and shared
with staff, volunteers
and,
stakeholders
A robust tender process has been carried out
which meets the requirements
ofthe project
and the successful contactor appointed
Extended car park is in use and meets needs of
the service users
3.2 Refurbishment
ofthe Hazel Centre to
Refurbishment
work
is completed,
include a new Cafe and commercial Kitchen commissioned,
and signed off, including
area compliance
registration
of fire safety
Redecoration
ofthe Hazel Centre communal
areas and refurbishment
ofoutdoor areas ofthe
cafe including
the purchase of new furniture
Cafe opening
hours increased
in a staged
approach
aiming for opening
seven days a
week, including
Christmas
Day
Feedback from employees,
patients
and wsitors
regarding
their experiences
ofthe Cafe
gathered
and a report produced.

3 3 Develop 3 3 Develop a portfolio of language that staff, Programme
of workshops
is in place to discuss
volunteers and our community
are
with employees
and volunteers
about the
comfortable with using regarding death, dying importance
of having
a common
language
about
and bereavement death and dying, which gives them confidence
when speaking to their networks
Mandatory
training
on the use of a common
language
about death and dying
is in place for
all employees
and volunteers
Employees
and volunteers
are surveyed
to
assess their understanding
ofthe common
agreed language
and the results analysed to
ensure that it is embedded
in the culture
Plan is in place to communicate
our ethos for a
common
language
about death and dying both
internally
and to the wider health community
3.4 Ensure Mountbatten's reach is wider and Develop links across all communities,
attending
equitable in terms ofaccess to services and meetings
and events where possible within the
suppolt communities
we support
Strengthen
links with Homelessness
support
services including
misuse of substance
services
and support
their development
around end-of-
life care and provision
Build on development
ofsupport/information
clinics within the Hazel Centre and widen the
network
Produce a Equality,
diversity
and inclusion
policy
Provide teaching sessions for Mountbatten
employees
related to the cultural
beliefs of all
community
groups and what
is important
to
them
Develop a procedure to support
staff when
caring for members ofany under-represented
gl'oup
Explore opportunities
to utilise the Hazel Centre
for diverse means

Overall rating for this service Overall rating for this service oviiwilulhc
u ize wzrzx wfrz iN~ ~
liui rierwe vilvriive i sow ~
1st Awfl.. zxzrz ootu~wx
nizvwr»ze errwnuw& duu~lw 0
li I,"4 wzv iv rri Ilxn ixnnawiw rz

Mountbatten Isle ofWight Isle ofWight
Media/Sites Vacancies Applications Hits
NHS Jobs 47 517 31,232
Indeed 40 378 47,512
IOW jobs 17 72 4,868
Other Platforms 40 2,152
Mountbatten Hampshire
Media/Sites Vacancies Applications Hits
NHS Jobs 65 350 52,175
Indeed 65 522 75,390
Other Platforms 252
Mountbatten Group
Media/Sites Vacancies Applications Hits
NHS Jobs 112 867 83,407
Indeed 105 900 122,902
IOW Jobs 17 72 4,868
Other Platforms 41 2,404

Our Workforce
As an organization,
we
are only as strong as We communicate
with our staff in many different
ways
We
the people we' re made up of. We pride run an ongoing series ofgeneral open meetings
to which
all
ourselves
on the ability
to recruit, develop, staff are invited
and at which any member ofstaff my raise
support
and train he best people
in each area
any issue or concern that they may have.
of our work. In order to do this, we need to
listen to our employees
and understand
what
kinds ofsupport,
information
and
development
opportunities
they want to see
from us.
We also have a policy whereby
all staff are able to have
regular and frequent
one to one meetings
with their line
manager
to discuss matters that relate directly to their day to
day work or how their work is affecting their day to day life.
We have a formal annual
process of appraisal
to formally
record the performance,
development
progress
and ambitions
and future plans for the employee
and the Chanty.
Finally, we have a formal process of whistleblowing
and an
identified
whistleblowing
'champion'
to faalitate
swift
disclosure
and resolution
to employment,
and other, issues
which
may be sensitive,
difficult or contentious
in nature.
Suppliers
We work with a range of suppliers
but given
While the nature of our activities means that our largest
our location and what it is that we do, they are expense is Human
Resources we still spend significant
mostly local suppliers. They do range from amounts
with external
supphers.
We are committed
to
small independents
to
members
of large and
treating
them fairly and ensure that as far as possible we pay
sometimes
international
corporate groups. them promptly
and deal with them equitably.
We run two
We value our relationships
with
all of our
creditor payment
runs every month to ensure that we are able
suppliers
and try hard to build good
to pay suppliers
promptly
and within agreed credit terms.
relationships
with
all ofour suppliers.

rv
la0
r4
o
0
4l th
O
th
I
01
vt
m
lh
r
IU
0
PV
ID
ch
I/I
Ca
IU
'llo
IU
IDo
m
Ol
IDD
Co
CO
IVo
rh
fa
m
m
Ol
r
ID
IO
00
14
ID
hl
o
fa
Itl
ca
IVo
fx
IU
IV
Ol
IU
Ol
Ol
CO
VVfa
C
Cla0
V
Vl0
tU
Cl
'0 4/ Ch ' O m DN
IUJ
Vl
Ct
ID
IU
00O
Ca
m
Ol
'0
41
IV
Va
at
at
fa
m
Ul
m
o
ID
m
C
Ct
E
'0
Cl
IJ
tU
4/ CI
m
m
o
IO
OI
co
at
co
m41
I
IU
va
Dl
af
ID
IU
oo
IO
ID
Ul
co
IVI
mm
IO
rh
m
CI
41
vl'm
ID
/V
oO
CO
ta
o
CI
IV
o
41
CO
o
Ca
Ia
Oo
a
IO
ID
co
Mat
tU
00
ta
'Cl
CJ
ta
Cl
0
IVO
14
0 4/ m
IO
fa
ID
la
m
th
ht
m
ao
ao
rh
CQ
ar
r
o
ID
m'
Olo
r
Ch
O
Ol
rh
IO
m
/4
m
Ul
Ol
Ul
t4
r
Ol
UJ
CO
Co
O
CJ
CI
CI
O
CI
CJ
I4
m41
CQ
00
rh
fflh
I
Co
Co
m
Ol
CQ
faIa
M
IO
Mo
I/I
Cl
D
0
10
CJ
IJ
4/
4l o
o
ca
m
0
tfl
m
' af
tx
Ch
rv
m
ca
Ol
mo
af
ID
O
Ifl
\0
CI' I
at
CI
m
at
M
m
0
C
to000
Ct
C
0
0VV
CI
4I
0
'00
'0
Ct
IJ
Vl
41
C
W ID
Ct
ra
Mm
IU
I/1
ra
at
m
ID
ca'
Ca
m
ca
al
m
H
00
ID
ar
/V
m'
r
Cho
r0
mo
I/I
ID
m
rri
th
m
m
O
co
oo ato
IO
Ch
r
IO
ID
r
ra
ooo
faaf
ID
ID
Co
ID
10
r
ra
Co
rri
oo tlo04
CI
Qt
00L
QI
4I
CLx Ql
Cl
lo0
0
CI
ta Cl
E04 0 ra ra IVI Cf Ul V
Cl
IO0
D
4C
N
Cl
C0
N0
lo40
VI
4I
NN0
O0
100
la
4
ta
tUt0
C
C0IJ
Cl CI
4I
E0
'0
IJ0
CI
Mla
IL
fa
0
0 4
CI 0
0. E ~
0 o m
QD th D
D
O
O
O
4I
la
lo
C 0
41
000
juW
V0
V
00
CJ
8
0
Eoo
0
C
4I 9
ro
E0
C
4 0 C
CI U
IU
taU
o
0
e
Io
U
C
0
U
CJ
4
000
ro
0
0
CI
E' S.
E
E DL
Cl
fo
0 4
I-
IU
'0
C
C
0
IU
4
ra
CI
ro
C
ta
J:
U
CJ
loU
rc
CI
C
e
0
C
0
U
&
C0
E
CI0
D
0
Cl
x
Cl
0
4I
0
Cl
Cl
E0IJC
0
'0
0
x
0
IUZ
0
0
E
v
.
C0
E
Cl
C
0
C
'ar
00
Nal
0
IU
Z
CI
0
41
0
C
Cl
~
D
4Itax
4I
Z
0
C
V
C
Ctat
Cl
Jo
Cl
taC
I-
0
0
O
CI
Z
N
'D
0
0
lo
0
lat
00
C
ra
0
0
Cl
CIIJ
D0
la
0I-
CI
Cl
CJ
0
al
0
fa
IU
0
c
CJ
E
fit
ta
C
0
tU
0Z

The Group Earl Mountbatten Hospice
2023 2022 2023 2022
Note E E
Fixed assets:
Tangible assets 12 11,693,046 11,718,873 11,217,448 11,282,700
Investments 13 31,629 7,810,840 2 5,910,849
11,724,675 19,529,713 11,217,450 17,193,549
Current assets:
Stocks 9,598 2,229
Debtors 16 689,763 3,819,692 542,822 1,922,060
Cash at bank and in hand 8,884,194 1,076,983 6,446,730 563,622
9,583,555 4,898,904 6,989,552 2,485,682
Liabilities:
Creditors: amounts falling due within one year 17 (2,296,596) (1,529,446) (938,949) (596,973)
Net current assets 7,286,959 3,369,458 6,050,603 1,888,709
Total net assets 20 19,011,634 22,899,171 17,268,053 19,082,258
Funds:
Restricted funds 3,194,784 3,221,019 3,194,784 3,221,019
Restricted funds CMH 220,950 239,486
Unrestricted
funds:
Designated
funds
9,573,435 9,573.435 9,073,435 9,073,435
General funds 6,022,465 9,865,231 4,999,834 6,787,804
Totalunrestricted funds 15,595,900 19,438,666 14,073,269 15,861,239
Total funds 21 19,011,634 22,899,171 17,268,053 19,082,258

Note 2023 2022
E E
Net cash provided
by
(used in) operating
activities 22 613,088 (351,464)
Cash flows from investing activities:
Dividends and interest 197,097 138,425
Purchase of property, plant and equipment (361,185) (535,835)
Proceeds from disposal of property, plant and
equipment 26,833
Proceeds from sale of investments 7,190,429 1,383,104
Purchase of investments (1,257,072) (1,689,251)
Movement
in portfolio
cash held for investment 1,424,854 (793,704)
Net cash used in investing activities 7,194,123 (1,470,428)
Change in cash and cash equivalents in the year 7,807,211 (1,821,892)
Cash and cash equivalents at the beginmng
ofthe
year 1,076,983 2,898,875
Cash and cash equivalents at the end ofthe year 8,884,194 1,076,983

ra
raO
rc
ta
0
I-
W Irl
ID
QI
mra
Nl
PC
I
Dl
r
ID
0
UI
ID
m
O
M
m
ID
r
M
ta C
4I
Cl
'0
00
W r
Ca
UI
m'
00
Irt
Ct
m'
I/I
CQ
ID
4I
4I
tU
Cl
V
N
Ql
mm M 0 00
CC
Cl
U
ra
40
40
0
V
4l tU
0
0 W M I/I
QI
V
tU
ID
trl
O
Ql
DI
I
CQ
ID
Ql
r
ID
ID
m
O
m
ID
ID
CQ
CI
IJ
0
IU
0
4 m 10C
o
tU
m
O
CC
0
0
w \0
m
Ql
00
O
Ca
cr
ca
ID
ra
f
rc
Dl
ra
tD
ra
m
ID
ra
ID
la 0
L
Ql
E
Ql
Ct 0
CIo
Cl
Ia4I
E
0
tU
IJ
Cl
CL
W m
CQ
CII
rMcr
CQ
oo
CI
Ulla
o
o
m
CQ
rn
W
IU
IU
CI
rc
IU0
ta
Cl
0
IJ
fa
Ll fa0 r
0 Cl Cl40
'0
V
N
CI
L
VJ r
IQ
r
M
cQ
rD
CQ
aa
at
I
cr
00
ID
ra
O
I/I
cc
la
Ql
cc
ID
rc
ID
cl'
rv
ra
CI
CI
CI
Ul
CI
Dl
IN00
Xl
Ul
C
0
IJ
Ia
IU
Itl
CL
Z 0
0
CI
CI
0
0
Ql
CI IJIJ
rc ta
IU
Ul IU
IU
10
N
Cl
CI
E
0C
IU
IJ
fa
ta
Oa0 IU
N ZlC Cl
IO
0
O
E
ECo
N
Nl
N C
la
IN
ta
—$ la
la
QI
C0
la
0
E0
U
0.
0Z
c
5
QtIJ
Cl.
0
Z
Ct
ta
Ja
0
Cl
U
0.
0Z
C
O
ClV
Cl
0
Z
C
Cl
ta
0
C
J:
Cl
0
Cl
IU
Cl
Cl
Cl
Cl0
Yl
QD .—Qa0
4I
C
la
Ia
0
N
4I
4I
0
0
Xzu.
Cl
E0IJC
CD fa
Ja
0
0
ra
UJ
Qf
0
u
V
Qt
fa
C
0
ra
Cl
tU
0
u
0
0
0
CI
IU
0
IU
S
'3
4:
Q
I/I
Cl
ta
u
/0
ruO
fu
0
0
w I/t
O'
ar
Q
Mm
Ol
O
«f
Ol
IO
trt
f
Ol
cr
fu
fu
Q
Q
fu
0
Ctl
Ol
fu
mIh
r
al'
fu
m
Cf
tu
Cl
Iu Iu
V
u4l
u/ Ch
m
cl'
IO
Ch
r
cr
CO
0
th
Cf
ru
r
IO
fu
Ih
00O
Ct
Ch
IO
tu
OI
IO
IV
O
00
CC' m
0
ta
V
W IO
O
m
Ch
00
/I
Ol
Q
Ca
m
rn
I/I
I
tuar
m
I/I
ru
Cl'
ru
fum
Ql
C
m ut CO
M
fuO
fu
0
0
l-
ul Ol
0
IO
m
O
OI
O
mthfu
IO
CO
/4
CO
M h IXI CO
ut CO CO
IU
IJ
m
CI
mQ m
Cl
Ch
Ifl
Ch
m
m
N
Ql
0 W m m
Ql
V
r
CC
O tu CI
CC Ol M
Ql M I/I
5/
N4I 0.
0
Q
N
Cl
IUIJ0.
0Z
a0
0e
44O
ru
v C
la
fh
IQ
0. —5
0 m
0 0
00 —40
IL 0
IU
4ID 00
laDve
0
e
4I
O
V 0
Xzw
ClDIa
IC
V
E0
Cl
E0VC
tO
CJ
I/I
Z
Z
0
U
ll
0Z
C
tU
ta
D
C
0
~
0
UJ
ClU
CL
0
Z
IU
fa
D
C
0
Qt
0
tu
W
I/I
Z
Z
0
U
'0.
I
0Z
C
Cl
ICD
C
0
&
Ql
ut
01
LI0.
0
Z
C
Ct
fa
C
Ql
C
0
0
CJ
QtIt
Qt 0
v Z
'0. C
tU
0Z
ta
Ql
C
0
fa
0 D
C
C 0
nl
0
aC 2
C
ct 0
CWtu
0
Qt
0
t/
faO
IU
CI0.
0
fa
0
C
0
E
0
CJ
Cl
V
C
V
00
5
0
0
0
IU
.U0.
Z
C
4I
Yll
C
&
Ql
Iu
4l
0!
CJ
C
E
E0
El
0
Cl0
I/I
'8
ClDla
Ia
IJ
E0
4l
E0IJ0
IC0
'0
Cl
4IIJ
4I
tll
Cl
E0IJC
UJ
I/IZ
ru
ruO
tu
e
0
ui m
ID
tdl
ch
ID
Ch
IVI
m
d'
r
id
ftl
r
ul
0
dr'
oi
ID
Ctl
ru
ruO
ru
td
0
w foal
00
r
O
id
ul
I/I
o
CQ
m
m
ru
'0
4I
IJ
tdl CO
CO
4' CI
dr
'0
QlJ
W
4l rd Cl
CC CC
'0
Cl
IJ
u
Cl
W r
Ch
IQ
ul
r
ID
ID
m
O
CO
00
ID
o
Cl
IU
ul m
r00
O
IV
ul
O
m
dr
CQ
m
m
IVO
(4
e
0
w \O d
dl'
I
CC
ID
IVI
O
iu
0
0
W
ru Ol
ID
rm
0
Cl
w tu
CO
' iu
dr
tu 0
Cl
W
U ID I/I
rh
Ol tJ
fu A
4I Cl
4l
IJ
u4I
0
ui Ul
CO
O
ul
I/I
CQ
dl'
ttl
OI
Io
Ih
ru
m
d
'cr
r
Ol
ID
m
00
m
/Im'
10
CJ
IJ
Cl
W ID
ru
dl'
O
IA
ID
ID
O
r
ttl
CI
'8
OI
0e m
E lu
e O
ldC
ld
th
td
O'V 2
C +
0 eC4e '0
C 0
4l
dl
Ow
e
0» e
4I
0XZ4
0 0
000
10
IC
Cl
0
E0
Cl
E0IJ0
0
IJ
000
dl
C
4J
U
Q
0
c
Cl
fll
0
uJ
dl
QlIJ0.
0
Z
dl
rd
C
0
C
U
0
U
C
tU
0
C
0
U
0
I/I
0.
0Z
C
e
td
C
0
td
UJ
Cl\J
td
JQ
C
N
C
0
U
0V0 IU
C
U
Cl
6.
E e 8
U Z
IU
0,
0 0
td
C Cl
Cl
0
C
tl! 0
E0 0
e + c
E—
0
td 0
U
UJ U
C
0 0 Ul 0
0
d
Vl
ca
Ol
aa
Ul1
Do
t
Ul
co
IIl
Ol
o
Ch
vt
0
UI
m
0
r
d
Do
Itl
Vl
ID
Da
m
0
Vl
CO
lt
r
ca 0
th
Vl
rn
m
N
O
Oo
0
d
0
CO
Ol
co
I
Ul
'd
co
co
Ol
Ch
m
CO
N
(1
M
r
N
r
IO
M
m
0
to
th
m
Ch
IO
(U O
m0 0 Ul
MO
N
ca
Ol
Ca
ar
Vl
1
(U
I
(U
m
00
(C
Ol
m
0
0 0
d
r'm
0 d
(1
m
N
0
oi
d
I
m
0
Ol
IO
Ol
ct
N
Ct
Ch
Ol
Ul
0
0
I
CO
Vl
m
IO
ID
Vl
r
N
m
r
Vl
ta
M
LD
N
0
N
rh
I
th
0lt
rCI
CI
m
Cl
m
CO
0
0
«L
W Ch
CI
\0lt
Ul
N
I
Ol
CO
ID
Ul
m
CI
m
0
r
vi
m
m
0
r
co
m
r
«h
r
ca
I
LD
ro
m
I
oo
CD
CO
m
Ol
o 0
N
m
CO
m
ch
0
Io
IL
Vl
Cl
0C
cl
W M
O
thI
' Ch
Ul
IID
Ol
Ul
Ol0
DoN
\O
UI
00
Dl E
E0V
Cl
V
UI rl
M
r
CI
Ch
Ch
Ch
O
Co
O0
(
Vl
m Ul
r
O
Ci
0
t
m
N
V4
cl
JJ
4
V
D
0
Cl
to
V
D
N 0
m(1
Ol
m
Ct
co
IO
(1
IO
vt
m
Itl
\D
0
Co
te
IV
Vl
I
IO
(
Ol
th
CO
Ol
m
N
0
N
IO
0
(1
Ol
d
ra
UI
r
Ch
CO
UI
ID
CO
CaN
O
4
CL0
aa
Tl
0
0 W UI
CO
Vl0
CO
(1
(1 Ol
m
Vl
0
r
O
0
0
m
0
Do
m
m
Vl
Ol
Ch
0
r
0tt rIO0
co
Ch lo
moto
oem
Ul I
Ca
DO
IO
CO
Do
CO
m
mr
tor
co (1
m
m
Vl
Ol
Vl
mm
m
0V
la
or
C0
IJ
C0 m al
E
CU
0 0
v Id
lo
Cn
OI
a —j
C0 m
0 —ZI
IL 0
g DID
0
IO
III0
ol
0
O
XZW
DIC
4la.
X
4I
000
loC
~I0Z
0
V
0
Clo0
00V
nt
V
la
CI
Dl
00a
X
Cl
0
0V
Cl
0
.—
C
E
Dlla
C
D
.e
U
ra
0
0
0V
Cct
0
0
ll
(D
0
Cl
Oa4
D
E
0
Ct
0
C
0
V
V4
llC4
0
4
C0
~I
0
Q
Cl
ao
0 tlDc
0
DV
0
E
CI
CL
I0D.
00
0
11
C
C0
4
J
CI
a
ID
Dl
U
C
I
a
E
0
Cl
U
0
4C
Cl
C0
00
DU
o
a
C
e
C
0
Q
CV
0
d
CI
4I
0
al
ClJl
Dl
E
C0V
Z
UJ
0
0
a
Ul
Z
V
0
0
a.
Vl
z
0V
Dl
UC0C
e
Z
0
U
e
UC
C
4
00
Pv
NON
4I
DD
0
0
I
CI
Cl
14C
~IO.
X
Cl
Ia0
IU
O
«w
0
«w
0
o
Pl
O
d
UI
co
Ch
co
IO
m
~0
d
ln
lo
th
0
I
r
O
M
Ol
m
UtO
Ul
0
00
Ch
Ut
h
0!
Co
N
m
0
Irl
Co
f
r
N
d
Co
N
lrl
m
Ul
O
Co
O
cr
O
00
0
N
co
lO
nr
ln
ao
CO
Ol
cn
IU
m
~0
I
m
N m
O
tfUl
m m
m
0
0
mlo
CO
IO
nr
\0«I
0
O
cr
O
Co
Ch
OU!
O
«I
N
O
O
«I
i
m
f
Ol
OI1 Ol
m
O.
Ul
Cl
V
«C
U UJ Co
0
I
' CO
N
i
IO
m
I
O
0
m
co
r
O
O
r
Cl
0
IO
U w m N
nr
o
nr
0
r
Ln
m
I nr«I Oi I
m
m
\0
Co O Co r
Cl 0 rn
U
nl
ClDta
ta ta
CI
C
4I
0 m
r
IO
ra O
N
IU
d
Co
4
IO
Ul
nl
0
Ul
Oi
0
m
rh
m
Ol
Co
UI
nrat
th
O
O
tn Co
Co
m
O
0
ta
CL
C
00
C
0
0 r
rn
0th
0
Ol
Ul
ra
O
r
d
Co
ch
m O O
Ul
IO
O
r
N
r
lo
m
ao
N
Cli
ca
r
d
IO
r
Co
r
UI
0 m m co r
0IJ
lo
Cl
0
a
0
4l M CI
E 04
4I
lo
lrl
CO
04
IJ
nl
o. —j
0
m
IL
ClD
C
4I
D«O
0
0!
4I
Cl
2ZW0
C
Cla«
Cl
0
lo
Cl
0Z
o
U
Ut
D
E
C0IJ
«
U
nn
0
C
«
Cl
0
0
~I
0
0
E
0
C0
Cl
I
C
0
000
tl0
0
V
Cl
0
CI
E
CI
0
00
0
C
nl
V00L
I
Cl
CI
«
C
0
U
0C0
~I0
C
0
C
lotn
Cl
0
V
00
C
CI
0
U
0
E
tU
tL
0
4!
0
01!
C
nl
0
U
ta
a0
CI
0
0
nl
C0
nlV
0 D
E a
0
C
«nl
tU
0
0
0
c a
0c
D
2
U
Cl
nl
0
0V
0
«
a
E
C0
U
Z
I
0
V
0
a
a
Ul
Z
U
0
0
a
a
Ul
Z
0
V
Cl
V
C
0
C
al
0
to
Z
U
0
V
4I
U
0
tn
L
tn
0
IU
4
CI
ra
4I
'00
4Io.
IC
Cl
la0
I

This is sta ted after char ging
2023 2022
E E
Depreciation 387,012 298,014
Operating lease rentals:
Property
- EMH
199,539 196,550
Property
- CMH
147,335 109,647
Auditor's remuneration (excluding VAT):
Audit - EMH 24,650 22,250
Audit - CMH 20,600 18,750
Other services - EMH 1,300 1,250
Other services —CMH 1,300 1,250
Staff costs were as Staff costs were as follows:
Current year 2023
EMH CMH Total
E E E
Staff under service level agreement with NHS 732,360 3,597,801 4,330,161
Wages and salaries 4,898,863 1,308,906 6,207,769
Employer's national insurance 466,615 368,934 835,549
Pension costs 545,763 419,656 965,419
Temporary and agency staff 907,991 400,014 1,308,005
Other staff costs 333,373 223,336 556,709
7,884,965 6,318,647 14,203,612
Prior year 2022
EMH CMH Tata
I
E E E
Staff under service level agreement with NHS 731,585 3,079,246 3,810,831
Wages and salaries 4,351,522 1,333,403 5,684,925
Employer's national insurance 396,510 291,71& 688,228
Pension costs 495,878 388,283 884,161
Temporary and agency staff 745,748 268,681 1,014,429
Other staff costs 224,077 234,379 458,456
6,945,319 5,595.710 12,541,030

The following
number
of employees
received employee
insurance)
during the year between:
benefits (excluding
employer
pension costs and
national
2023 2022
No. No.
E60,000 - E69,999 1 1
E70,000 - E79,999 1 1
E80,000 —E89,999 2 1
E90,000 - E99,999 1 1
E100,000 - E109,999 1
E110,000 - E119,999

9.
St
aff numbers
2023 2023 2022 2022
Employed Recharged Employed Recharged
by Charity to Charity by Charity to Charity
No. No. No. No.
Fundraising - EMH 11 10
Fundraising -CMH 5 32
In patient unit / Patient services - EMH 68 52
In patient unit / Patient serwces - CMH 79 137
Community 107 56
Day unit / JCC 18 10
Retail 61 4(
Support 80 43
429 381

12.
Tangible fixe
d assets
Fixtures,
Land and Leasehold fittings and Motor
Group buildings improvements equipment vehicles Total
E E E E E
Cost
At the start of the year 11,112,676 250,674 2,454,453 261,197 14,079,000
Additions
in year
57,433 35,858 265,394 2,500 361,185
Disposals
in year
Transfers (136,940) 136,940
At the end ofthe year 11,033,169 423,472 2,719,847 263,697 14,440,185
Depreciation
At the start ofthe year 153,372 43,126 1,961,745 201,884 2,360,127
Charge for the year 13,042 75,746 271,939 26,285 387,012
Depreciation
ehminated
on disposal
Transfers (122,951) 122,951
At the end ofthe year 43,463 241,823 2,233,684 228,169 2,747,139
Net book value
At the end ofthe year 10,989,706 181,649 486,163 35,528 11,693,046
At the start ofthe year 10,959,304 207,548 492,708 59,313 11,718,873
Freehold Fixtures,
land and Leasehold fittings and Motor
Earl Mountbatten
Hospice
buildings improvements equipment vehicles Total
E E E E E
Cost
At the start ofthe year 11,062,094 2,031,583 261,197 13,354,874
Additions
in year
55,860 27,555 83,415
Disposals
in year
Transfers (136,940) 136,940
At the end ofthe year 10,981,014 136,940 2,059,138 261,197 13,438,289
Depreciation
At the start ofthe year 122,951 1,747,339 201,884 2,072,174
Charge for the year 7,760 115,117 25,790 148,667
Depreciation
eliminated
on disposal
Transfers (122,951) 122,951
At the end ofthe year 130,711 1,862,456 227,674 2,220,841
Net book value
At the end ofthe year 10,981,014 6,229 196,682 33,523 11,217,448
At the start ofthe year 10,939,143 284,244 59,313 11,282,700

Group Earl Mountbatten Hospice
2023 2022 2023 2022
E E E E
Listed investments
Fair value at the start ofthe year 6,385,986 5,794,747 4,827,958 4,462,912
Additions at cost 1,257,071 1,689,251 955,107 1,319,277
Disposal proceeds (7,190,428) (1,383,104) (5,463,195) (1,078,776)
Net (loss)/gain
on change
in fair value (421,000) 285,092 (319,870) 124,545
31,629 6,385,986 4,827,958
Cash held by investment broker pending
reinvestment 1,424,854 1,082,889
Investment in group undertaking
Fair value at the end ofthe year 31,629 7,810,840 2 5,910,849
2023 2022
E E
UK Bonds 497,542
Overseas Bonds 31,629 426,507
UK Equities 1,662,869
North American Equities 1,560,358
European Equities 407,543
Japanese Equities 220,427
Asia Pacific Equities 523,137
Emerging Market Equities 99,881
Global Investments 298,476
Absolute Return 208,631
Property Trusts 212,522
Other 268,093
Cash 1,424,854
31,629 7,810,840

Countess
Countess Mountbatten Earl
Mountbatten Hospice Mountbatten
Hospice Charity Promotions Hospice Trading
Year ended 31March 2023 Limited l.imited Limited
6 E E
Income/
turnover
6,968,189 402,733 104,069
Cost of sales (131,389) (8,461)
Net income/ gross profit 6,968,189 271,344 95,608
Net expenditure
/
administratwe expenses (9,182,898) (18,202) (36,158)
Distribution from subsidiary 482,590
Loss on investment assets (101,130)
Net income/(expenditure)/profit/(loss) for the financial
year (1,833,249) 253,142 59,450
Funds/retamed
earnings
brought
forward 3,339,377 477,536
Net income/(expenditure)/profit/(loss) for the financial
year (1,833,249) 253,142 59,450
Distribution under Gift Aid to parent charity (482,590) (59,450)
Reserves/retained earnings carried forward 1,506,128 248,088
The aggregate of the assets, kabilities and funds was:
Assets 2,927,144 288,307 27,333
Liabilities (1,421,016) (40,217) (27,331)
Funds 1,506,128 248,090

Countess
Countess Mountbatten Earl
Mountbatten Hospice Mountbatten
Hospice Charity Promotions Hospice Trading
Year ended 31March 2022 Limited Limited l.imited
E E E
Income / turnover 9,335,716 373,587 78,305
Cost ofsales (118,092) (6,699)
Net mcome/gross profit 9,335,716 255,495 71,606
Net expenditure/administratwe expenses (8,028,476) (26,047) (35,893)
Distnbution
from
subsidiary 57,660
Gain on investment assets 160,547
Net (expenditure)/profit
for
the finanmal year 1,525,447 229,448 35,713
Funds/retained
earnings
brought
forward 1,813,930 305,748 (2,195)
Net income/(expenditure)/profit/(loss) for the financial year 1,525,447 229,448 35,713
Distribution
under
Gift Aid to parent charity (57,660) (33,518)
Reserves/retained earnings earned forward 3,339,377 477,536
The aggregate ofthe assets, liabilities and funds was:
Assets 4,738,226 535,666 37,019
Liabilities (1,398,849) (58,128) (37,017)
Funds 3,339,377 477,538

2023 2022
E E
Gross income 8,784,402 10,471,563
Result for the year (1,814,204) 1,272,168
16. Debtors
Group Earl Mountbatten Hospice
2023 2022 2023 2022
E E E E
Amounts due from group entities 22,732 211,712
Trade debtors 243,165 81,012 203,812 24,034
Accrued income and other debtors 168,864 3,418,215 130,330 1,452,771
VAT recoverable 99,956 148,381 59,140 97,057
Prepayments 177,778 172,084 126,808 136,486
689,763 3,819,692 542,822 1,922,060
17.
Creditors: amounts
falling due wi
thin one year
Group Earl Mountbatten Hospice
2023 2022 2023 2022
E E E E
Trade creditors 447,381 556,061 246,376 258,256
Deferred income 69,718 69,718 69,718 69,718
Other creditors and accruals 1,779,497 903,667 613,781 268,999
Amounts due to group entities 9,074
2,296,596 1,529,446 938,949 596,973

Group Earl Mountbatten Hospice
2023 2022 2023 2022
E E E E
Balance at the beginning
ofthe year
69,718 623,041 69,718 318,041
Amount released to income in the year (553,323) (248,323)
Amount deferred m the year
Balance at the end ofthe year 69,718 69,718 69,718 69,718

20.a)
Analysis ofgroup net assets between
funds - 2023
General Designated Restricted Total
unrestricted funds funds funds
E E E E
Tangible fixed assets 372,201 9,020,915 2,299,930 11,693,046
Investments 31,629 31,629
Net current assets 5,618,635 552,520 1,115,804 7,286,959
Net assets atthe end ofthe year 6,022,465 9,573,435 3,415,734 19,011,634
20.a)
Analysis ofgroup net assets between
funds
-2022
General Designated Restricted Total
unrestricted funds funds funds
E E E E
Tangible fixed assets 368,040 9,020,915 2,329,918 11,718,873
Investments 7,310,840 500,000 7,810,840
Net current assets 2,186,351 52,520 1,130,587 3,369,458
Net assets atthe end ofthe year 9,865,231 9,573,435 3,460,505 22,899,171

21.a) Mov e ment
in funds
- 2023
At 1 Apnl Gain on At 31
2022 Income Expenditure revaluations Transfers March 2023
E E E E E E
Restricted funds
Capital funds
John Cheverton
estate
fixed
asset fund 74,274 (29,988) 44,286
Fixed Asset Fund 2,255,644 2,255,644
Revenue funds
Community
equipment
2,678 (2,678)
Clinical Co-ordination Centre 192,057 (150,844) 41,213
iBCF 97,227 80,000 (143,223) 34,004
Kelly donation 505 505
Young adult services 56,584 (33,875) 22,709
DC clinical teaching post 15,171 (15,171)
NHS CCG - CQUINs 39,038 39,038
KissyPuppy
restricted
fund 341,513 113,591 (55,524) 399,580
Advanced
communication
4,651 (903) 3,748
MND Clinic 9,451 (2,524) 6,927
Responsible
communities
65,075 (65,075)
Mountbatten
young
adults 5,114 (2,645) 2,469
Barclays donation 75,276 (8,998) 66,278
Ward Furniture 4,616 (3,604) 1,012
Oak Garden
Decking
5,500 (5,500)
Butterfly &Chelsea Garden
Maintenance 5,000 (5,000)
Bladder Scanners 8,000 (917) 7,083
Hoist Pods for IPU 4,560 (880) 3,680
Essential
Equipment
for patient
Care 4,618 2,200 (2,555) 4,263
Gen Don-Community 12,681 (12,681)
Gen Don-Lymphoedema 100 (100)
Donations for Staff 703 (703)
JC Pool Vehicle Fund 250,000 250,000
Daisy Rich Trust 1,000 1,000
Hospital
Saturday
Fund
2,000 2,000
Other restricted
funds
8,676 1,011 (342) 9,345
Total restricted
funds
EMH 3,221,019 517,495 (543,730) 3,194,784
21 .a) M o veme nt
in fund
s —2023 (cont.)
At 31
At 1 April Gain on March
2022 Income Expenditure revaluations Transfers 2023
E E E E E E
Restricted funds - CMH
NHSE 98,870 (27,070) 71,800
Other 140,616 81,437 (72,903) 149,150
Total restricted funds 3,460,505 598,932 (643,703) 3,415,734
Unrestricted funds -EMH
Designated funds:
Fixed Asset Fund 9,073,435 9,073,435
Total designated funds - EMH 9,073,435 9,073,435
Designated funds - CMH 500,000 500,000
Total designated funds 9,573,435 9,573,435
General funds —EMH group 5,957,898 7,275,552 (9,749,624) (319,870) 3,163,956
General funds —CMH group 3,907,333 7,289,486 (8,237,180) (101,130) 2,858,509
Total unrestricted funds 19,438,666 14,565,038 (17,986,804) (421,000) 15,595,900
Total funds - EMH 18,252,351 7,793,047 (10,293,354) (319,870) 15,432,174
Total funds - CMH 4,646,820 7,370,923 (8,337,153) (101,130) 3,579,460
Total funds 22,899,171 15,163,970 (18,630,507) (421,000) 19,011,634

21.b)
Movemen
t in funds - 2022
At 1April Gain on At 31March
2021 Income Expenditure revaluation 2022
E E E E E
Restricted funds
Capital funds
John Cheverton
estate
fixed asset fund 111,576 (37,302) 74,274
Fixed Asset Fund 2,255,644 2,255,644
Revenuefunds
Community
equipment
12,475 (9,797) 2,678
Clinical Co-ordination Centre 333,521 (141,464) 192,057
iBCF 159,566 73,333 (135,672) 97,227
Kelly donation 505 505
Young adult services 68,967 20,000 (32,383) 56,584
DC clinical teachmg post 13,246 (13,2461
NHS CCG -CQUINs 41,139 (41,1391
Hospital discharge co-ordinator grant 1 (1)
KissyPuppy
restncted
fund 269,148 100,810 (28,445) 341,513
Advanced
communication
4,651 4,651
MND Clinic 12,205 (2,754) 9,451
Responsible
communities
66,750 (1,675) 65,075
Mountbatten
young
adults 5,144 (30) 5,114
Barclays donation 92,156 (16,880) 75,276
NHSE 1,439,619 (1,439,619)
Ward Furniture 8,707 (4,091) 4,616
Education
Fund
4,215 (4,215)
Oak Garden
Decking
5,500 5,500
Butterfly &Chelsea Garden
Maintenance 5,000 5,000
Online Bereavement support 2,584 (2,584)
Infection Control Salary Costs 14,366 (14,366)
Bladder Scanners 9,000 (1,000) 8,000
Hoist Pods for IPU 5,520 (960) 4,560
Essential
Equipment
For patient Care 4,954 (336) 4,618
SPOC/Palliative
Care
Hub 47,593 (47,593)
Music Therapy 3,000 (3,000)
Rodwell donation 250,000 (250,000)
Other restricted
funds
8,211 13,371 (12,906) 8,676
Total restricted
funds
EMH 3,400,520 2,601,957 (2,241,458) 3,221,019

21.b) Move ment
in funds —2022 (cont.)
At 31
At 1April Gain on March
2021 Income Expenditure revaluation 2022
6 E 6 E 6
Restricted funds - CMH
NHSE 2,267,249 (2,168,379) 98,870
Other 131,934 120,398 (111,716) 140,616
Total restricted
funds
3,460,505 4,449,604 (4,521,553) 3,460,505
Unrestricted funds -EMH
Designated funds:
Fixed Asset Fund 9,073,435 9,073,435
Total designated
funds - EMH
9,073,435 9,073,435
Designated funds - CMH 500,000 500,000
Total designated
funds
9,573,435 9,573,435
General funds —EMH group 5,393,484 7,534,944 (7,095,184) 124,654 5,957,898
General funds —CMH group 1,487,746 7,321,656 (5,062,616) 160,547 3,907,333
Total unrestricted funds 16,454,665 14,856,600 (12,157,800) 285,201 19,438,666
Total funds - EMH 17,867,439 9,596,900 (9,336,642) 124,654 18,252,351
Total funds - CMH 2,119,680 9,709,304 (7,342,711) 160,547 4,646,820
Total funds 19,987,119 19,306,204 (16,679,353) 285,201 22,899,171

2023 2022
E E
Net (expenditure)/income
for the reporting
period (3,887,537) 2,912,052
(as per the statement offinancial activities)
Depreciation
charges
387,012 311,608
Profit on disposals offixed assets (13,594)
(Gains)/losses
on investments
421,000 (285,092)
Dividends,
interest
and rent from investments (197,097) (138,425)
(Increase)/decrease in stocks (7,369) 1,205
Decrease/(increase) in debtors 3,129,929 (2,559,546)
Increase/(Decrease) in creditors 767,150 (579,672)
Net cash (used in)/provided by operating activities 613,088 (351,464)
Analysis of cash and «ash equivalents
2023 2022
E E
Cash
in hand
8,884,194 1,076,983
Analysis ofchanges in net debt
1 April Cash flows 31March
2022 2023
E E
Cash in hand 1,076,983 7,807,211 8,884,194

Group Earl Mountbatten Hospice
2023 2022 2023 2022
E E E E
Less than one year 347,398 306,275 156,898 160,441
One to five years 1,276,558 805,333 593,725 382,667
Over five years 784,117 11,250 355,200
2,048,073 1,122,858 1,105,823 543,108